Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 29 Neoplasms 12 Lung Neoplasms 11 Endometrial Neoplasms 11 Stomach Neoplasms 10 Lymphatic Metastasis 7 Head and Neck Neoplasms 7 Melanoma 6 Esophageal Neoplasms 6 Carcinoma, Hepatocellular 6 Uterine Cervical Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Rectal Neoplasms 4 Ovarian Neoplasms 4 Sarcoma 3 Prostatic Neoplasms 3 Lymphedema 3 Colorectal Neoplasms 3 Brain Neoplasms 3 Vulvar Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solitary Pulmonary Nodule 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Osteosarcoma 2 Multiple Pulmonary Nodules 2 Margins of Excision 2 Giant Cell Tumor of Bone 2

Interventions

trametinib 1 talimogene laherparepvec 1 spartalizumab 1 pembrolizumab 1 nazartinib 1 exemestane 1 canakinumab 1 Telomerase 1 Tamoxifen 1 Surgical Procedures, Operative 1 Specimen Handling 1 Sentinel Lymph Node Biopsy 1 Pemetrexed 1 Paclitaxel 1 Mastectomy, Subcutaneous 1 Mastectomy, Segmental 1 Mammaplasty 1 Letrozole 1 Indocyanine Green 1 Doxorubicin 1 Docetaxel 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Ductal × Indocyanine Green × Clear all

NCT01796041 2021-01-28

ICG

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Completed

Carcinoma, Lobular, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡